Cargando…
Privacy Implications of Contacting the At-Risk Relatives of Patients with Medically Actionable Genetic Predisposition, with Patient Consent: A Hypothetical Australian Case Study
Genetic risk information has relevance for patients’ blood relatives. However, cascade testing uptake in at-risk families is <50%. International research supports direct notification of at-risk relatives by health professionals (HPs), with patient consent. However, HPs express concerns about the...
Autores principales: | Tiller, Jane, Nowak, Kristen, Boughtwood, Tiffany, Otlowski, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296322/ https://www.ncbi.nlm.nih.gov/pubmed/37366793 http://dx.doi.org/10.3390/biotech12020045 |
Ejemplares similares
-
Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public
por: Tiller, Jane M., et al.
Publicado: (2023) -
Study protocol: the Australian genetics and life insurance moratorium—monitoring the effectiveness and response (A-GLIMMER) project
por: Tiller, Jane, et al.
Publicado: (2021) -
Health professionals’ views and experiences of the Australian moratorium on genetic testing and life insurance: A qualitative study
por: Dowling, Grace, et al.
Publicado: (2022) -
Disclosure to genetic relatives without consent – Australian genetic professionals’ awareness of the health privacy law
por: Meggiolaro, Natalia, et al.
Publicado: (2020) -
Should Australia Ban the Use of Genetic Test Results in Life Insurance?
por: Tiller, Jane, et al.
Publicado: (2017)